Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

247.85
Delayed Data
As of Jul 25
 -1.13 / -0.45%
Today’s Change
195.50
Today|||52-Week Range
340.34
-20.69%
Year-to-Date
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Allergan, Alaska Air, Tableau, PulteGroup and More
Jul 25 / TheStreet.com - Paid Partner Content
Weitz Funds Comments on Allergan
Jul 20 / GuruFocus News - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Weitz Funds' 2nd Quarter 2016 Value Fund Commentary
Jul 20 / GuruFocus News - Paid Partner Content
Synergy Pharma Offers Lots of Synergies
Jul 22 / TheStreet.com - Paid Partner Content
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary
Jul 20 / GuruFocus News - Paid Partner Content
Synergy Pharma Offers Suitors Lots of Synergy
Jul 22 / TheStreet.com - Paid Partner Content
Teva taps euro bond market ahead of ECB meeting
Jul 20 / FT.com - Paid Partner Content

Today’s Trading

Previous close248.98
Today’s open250.00
Day’s range246.07 - 250.31
Volume2,163,405
Average volume (3 months)4,647,148
Market cap$98.5B
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+5.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.51+0.80%
LLYEli Lilly and Co+0.39+0.48%
GSKGlaxoSmithKline+0.16+0.36%
NVONovo Nordisk-0.33-0.59%
Data as of 07/25/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.32
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs